“Pulmonary Covid Fibrosis a new pharmaceutical approach”
Authors: Menicagli r
Date: 2020
Scope of interest: infectivology
06 99 39
Recup number
You may also be interested in:
Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.
Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).
Date: 2012
Scope of interest: Hematology/Transfusion Medicine
Read details
Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations.
Authors: Lapenta L, Morano A, Casciato S, Fanella M, Fattouch J, Vaudano AE, Gregori B, Vanacore N, Manfredi M, Giallonardo AT, Di Bonaventura C.
Date: 2014
Scope of interest: Epilepsy
Read details
Management of anaemia secondary to epistaxis in patients with Rendu Osler disease the role of IV martial therapy
Authors: M.Trimboli - F. De Angelis - F.Docimo – E.Gigliotti - G.Guiducci – P.Paesano – I.Provenzano – C.D'Amico – S.Fornella – S.Romoli – A.Di Folco- C. Gargiulo
Date: 2022
Scope of interest: Hematology/Transfusion Medicine
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
